Cargando…
Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis
Background: To investigate the efficacy and safety of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 in episodic migraine (EM) prevention. Methods: A pilot, single-arm, open-label study was conducted. After a one-month baseline p...
Autores principales: | Vikelis, Michail, Dermitzakis, Emmanouil V., Vlachos, George S., Soldatos, Panagiotis, Spingos, Konstantinos C., Litsardopoulos, Pantelis, Kararizou, Evangelia, Argyriou, Andreas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794912/ https://www.ncbi.nlm.nih.gov/pubmed/33375459 http://dx.doi.org/10.3390/jcm10010067 |
Ejemplares similares
-
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
por: Vikelis, Michail, et al.
Publicado: (2018) -
Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
por: Argyriou, Andreas A., et al.
Publicado: (2023) -
Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study
por: Vikelis, Michail, et al.
Publicado: (2017) -
Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
por: Vikelis, Michail, et al.
Publicado: (2023) -
Onabotulinumtoxin-A treatment in Greek patients with chronic migraine
por: Vikelis, Michail, et al.
Publicado: (2016)